Does BORTEZOMIB Cause Cholangiocarcinoma? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Cholangiocarcinoma have been filed in association with BORTEZOMIB (bortezomib). This represents 0.0% of all adverse event reports for BORTEZOMIB.
17
Reports of Cholangiocarcinoma with BORTEZOMIB
0.0%
of all BORTEZOMIB reports
4
Deaths
4
Hospitalizations
How Dangerous Is Cholangiocarcinoma From BORTEZOMIB?
Of the 17 reports, 4 (23.5%) resulted in death, 4 (23.5%) required hospitalization, and 5 (29.4%) were considered life-threatening.
Is Cholangiocarcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BORTEZOMIB. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does BORTEZOMIB Cause?
Plasma cell myeloma (6,683)
Off label use (4,754)
Neuropathy peripheral (4,067)
Drug ineffective (2,730)
Diarrhoea (2,244)
Thrombocytopenia (2,082)
Death (2,025)
Pneumonia (2,020)
Fatigue (1,757)
Neutropenia (1,530)
What Other Drugs Cause Cholangiocarcinoma?
RANITIDINE (100)
ADALIMUMAB (62)
TACROLIMUS (56)
METHOTREXATE (55)
INFLIXIMAB (54)
LENALIDOMIDE (49)
PREDNISONE (48)
MYCOPHENOLATE MOFETIL (45)
PEMIGATINIB (44)
CYCLOPHOSPHAMIDE (42)
Which BORTEZOMIB Alternatives Have Lower Cholangiocarcinoma Risk?
BORTEZOMIB vs BOSENTAN
BORTEZOMIB vs BOSENTAN\BOSENTAN
BORTEZOMIB vs BOSULIF
BORTEZOMIB vs BOSUTINIB
BORTEZOMIB vs BOTOX